Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls

BMC Pulm Med. 2014 Sep 2:14:144. doi: 10.1186/1471-2466-14-144.

Abstract

Background: Viral pathogens were more commonly reported than previously estimated in community-acquired pneumonia (CAP) patients. However, the real role of virus was still controversial.

Methods: Consecutive adult patients with CAP between April and December, 2009 were prospectively enrolled. A four-fold or greater increase of IgG-titres against respiratory viruses in pair sera was tested by means of hemagglutination inhibition assay or indirect immunofluorescence. Swab samples were tested by cell culture and/or nucleic amplification tests. Viral etiology was considered definitive if at least one of the above tests was positive.

Results: Viral etiology was established in fifty-two (34.9%) of 149 CAP patients, twenty-two (81.5%) of 27 influenza like illness patients, and none of 75 volunteer controls. Forty-seven CAP patients were infected by a single virus (24 influenza A virus, 5 influenza B, 10 parainfluenza virus type 3 [PIV-3], 2 PIV-1, 2 adenovirus, 2 human rhinovirus and 2 coronavirus OC43), five cases by two or three viruses co-infection. Fever ≥ 39 °C (66.7%), fatigue (64.6%), and purulent sputum (52.1%) was the most common symptoms in viral pneumonia patients. On multivariate analysis, myalgia was included in the model for pneumonia associated with influenza infection. In the CURB-65 model only influenza infection was found independently associated with severe disease (CURB-65 score ≥ 3) out of variables, including age(years), sex, current smoking status, sick contact with febrile patients, numbers of comorbidity, presence of influenza infection, presence of PIV infection, with P = 0.021, OR 7.86 (95% CI 1.37-45.04).

Conclusion: Respiratory virus was not a bystander, but pathogenic in pneumonia and was a common cause of CAP.

Publication types

  • Comparative Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / immunology
  • Adenoviridae Infections / blood
  • Adenoviridae Infections / virology*
  • Adult
  • Aged
  • Antibodies, Viral / blood*
  • Coinfection / virology
  • Community-Acquired Infections / blood
  • Community-Acquired Infections / virology
  • Coronavirus / immunology
  • Coronavirus Infections / blood
  • Coronavirus Infections / virology
  • Female
  • Healthy Volunteers
  • Humans
  • Immunoglobulin G / blood*
  • Influenza A virus / immunology
  • Influenza B virus / immunology
  • Influenza, Human / blood
  • Influenza, Human / virology
  • Male
  • Middle Aged
  • Parainfluenza Virus 1, Human / immunology
  • Parainfluenza Virus 3, Human / immunology
  • Picornaviridae Infections / blood
  • Picornaviridae Infections / virology
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / virology*
  • Prospective Studies
  • RNA Virus Infections / blood
  • RNA Virus Infections / virology*
  • Respirovirus Infections / blood
  • Respirovirus Infections / virology
  • Rhinovirus / immunology

Substances

  • Antibodies, Viral
  • Immunoglobulin G